Supervised disulfiram in relapse prevention in alcohol-dependent patients suffering from comorbid borderline personality disorder-A case series

Alcohol and Alcoholism

Volumn 45, Issue 2, 2010, Pages 146-150

  Mutschler, Jochen ^a,b   Grosshans, Martin ^a   Koopmann, Anne ^a   Hermann, Derik ^a   Diehl, Alexander ^c   Mann, Karl ^a   Kiefer, Falk ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^c KLINIKUM BRAUNSCHWEIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BENZODIAZEPINE; CITALOPRAM; DISULFIRAM; ESCITALOPRAM; LAMOTRIGINE; MIRTAZAPINE; OLANZAPINE; OXCARBAZEPINE; PREGABALIN; QUETIAPINE; TRIMIPRAMINE; VALPROIC ACID;

ADULT; ALCOHOL ABSTINENCE; ALCOHOLISM; ARTICLE; BORDERLINE STATE; CASE STUDY; CLINICAL ARTICLE; COMORBIDITY; DIZZINESS; DRUG ALCOHOL INTERACTION; DRUG DEPENDENCE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MALE; MALE SEXUAL DYSFUNCTION; MENTAL DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RELAPSE; SUICIDAL BEHAVIOR; TREATMENT RESPONSE;

ADULT; ALCOHOL DETERRENTS; ALCOHOLISM; BORDERLINE PERSONALITY DISORDER; COMBINED MODALITY THERAPY; DIAGNOSIS, DUAL (PSYCHIATRY); DISULFIRAM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PSYCHOTHERAPY; RECURRENCE; SUBSTANCE ABUSE TREATMENT CENTERS; TEMPERANCE; TREATMENT OUTCOME;

EID: 77949343120     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agq001     Document Type: Article

References (33)

1. Aberg J. (1984) Antabus is unsuitable in treatment of borderline personalities. Lakartidningen 81:3684-5.
2. Anton RF, O'Malley SS, Ciraulo DA et al. (2006) Combined pharmacotherapies and behavioural interventions for alcohol dependence: the COMBINE Study: a randomized controlled trial. JAMA 295:2003-17.
3. Arolfo MP, Overstreet DH, Yao L et al. (2009) Suppression of heavy drinking and alcohol seeking by a selective ALDH-2 inhibitor. Alcohol Clin Exp Res 33:1935-44. Epub 2009 Aug 10.
4. Berglund M, Thelander S, Salaspuro M et al. (2003) Treatment of alcohol abuse: an evidence-based review. Alcohol Clin Exp Res 27:1645-56.
5. Brewer C. (1990) Combining pharmacological antagonists and behavioural psychotherapy in treating addictions. Why it is effective but unpopular. Br J Psychiatry 15734-40.
6. Chick J. (1999) Safety issues concerning the use of disulfiram in treating alcohol dependence. Drug Saf 20:427-35.
7. Chick J, Lehert P, Landron F. (2003) Does acamprosate improve reduction of drinking as well as aiding abstinence? J Psychopharmacol 17:397-402.
8. de Sousa A, de Sousa A. (2004) A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence. Alcohol Alcohol 39:28-31.
9. de Sousa A, de Sousa A. (2005) An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol 40:545-8.
10. Diehl A, Ulmer L, Mutschler J et al. (2010) Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long term study in 353 alcohol dependent patients. Alcohol Alcohol in press.
11. Dimeff LA, Linehan MM. (2008) Dialectical behaviour therapy for substance abusers. Addict Sci Clin Pract 4:39-47.
12. Echeburúa E, Bravo De Medina R, Aizpiri J. (2007) Comorbidity of alcohol dependence and personality disorders: a comparative study. Alcohol Alcohol 42:618-22.
13. Ehrenreich H, Krampe H. (2004) Does disulfiram have a role in alcoholism treatment today? Not to forget about disulfiram's psychological effects. Addiction 99:26-7.
14. Enghusen Poulsen H, Loft S, Andersen JR et al. (1992) Disulfiram therapy-adverse drug reactions and interactions. Acta Psychiatr Scand Suppl 369:59-65.
15. Fuller RK, Gordis E. (2004) Does disulfiram have a role in alcoholism treatment today? Addiction 99:21-4.
16. Hilwerling L, Assmann K, Waehner A et al. (2007) Levetiracetam and disulfiram for relapse prevention in patients with alcohol dependence. Alcohol Alcoholism Suppl 42:43-4.
17. Krampe H, Stawicki S, Wagner T et al. (2006) Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome. Alcohol Clin Exp Res 30:86-95.
18. Krampe H, Wagner T, Stawicki S et al. (2006) Personality disorder and chronicity of addiction as independent outcome predictors in alcoholism treatment. Psychiatr Serv 57:708-12.
19. Kranzler HR, Del Boca FK, Rounsaville BJ. (1996) Comorbid psychiatric diagnosis predicts three-year outcomes in alcoholics: a posttreatment natural history study. J Stud Alcohol 57:619-26.
20. Laaksonen E, Koski-Jannes A, Salaspuro M et al. (2008) A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol 43:53-61.
21. Lieb K, Völlm B, Rücker G et al. (2010) Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Br J Psychiatry 196:4-12.
22. Mann K. (2004) Pharmacotherapy of alcohol dependence: a review of the clinical data. CNS Drugs 18:485-504.
23. Mutschler J, Diehl A, Kiefer F. (2008a) Pharmacology of disulfiram-an update. Fortschr Neurol Psychiatr 76:225-31.
24. Mutschler J, Diehl A, Vollmert C et al. (2008b) Recent results in relapse prevention of alcoholism with disulfiram. Neuropsychiatry 22:243-51.
25. Neto D, Lambaz R, Tavares JE. (2007) Compliance with aftercare treatment, including disulfiram, and effect on outcome in alcohol-dependent patients. Alcohol Alcohol 42:604-9.
26. Pettinati HM, Pierce JD Jr, Belden PP et al. (1999) The relationship of axis ii personality disorders to other known predictors of addiction treatment outcome. Am J Addict 8:136-47.
27. Preuss UW, Johann M, Fehr C et al. (2009) Personality disorders in alcohol-dependent individuals: relationship with alcohol dependence severity. Eur Addict Res 15:188-95.
28. Ralevski E, Ball S, Nich C et al. (2007) The impact of personality disorders on alcohol-use outcomes in a pharmacotherapy trial for alcohol dependence and comorbid axis i disorders. Am J Addict 16:443-9.
29. Stepp SD, Trull TJ, Sher KJ. (2005) Borderline personality features predict alcohol use problems. J Pers Disord 19:711-22.
30. Suh JJ, Pettinati HM, Kampman KM et al. (2006) The status of disulfiram: a half of a century later. J Clin Psychopharmacol 26:290-302.
31. Trull TJ, Sher KJ, Minks-Brown C et al. (2000) Borderline personality disorder and substance use disorders: a review and integration. Clin Psychol Rev 20:235-53.
32. Weinshenker D, Schroeder JP. (2007) There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology 32:1433-51.
33. Wolwer W, Burtscheidt W, Redner C et al. (2001) Out-patient behaviour therapy in alcoholism: impact of personality disorders and cognitive impairments. Acta Psychiatr Scand 103:30-7.